Dr. Morris Rosenberg

Ardeagen is leveraging over 30 years of biologics drug development experience of its founder, Morris Z. Rosenberg.  In addition to Dr. Rosenberg, the Ardeagen team is supported by a network of highly experienced consultants, CRO’s, and CMO’s.   Dr. Rosenberg established these relationships over the past twenty years while developing several antibody drug conjugate candidates that are presently in the clinic or on the market.